| Date Filed | Type | Description |
| 05/03/2018 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 04/30/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/30/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/30/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/30/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/30/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/30/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/30/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/30/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/24/2018 |
8-K
| Quarterly results |
| 04/23/2018 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/23/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/23/2018 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/10/2018 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/30/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 03/26/2018 |
SC 13D/A
| Accelmed Growth Partners, L.P. reports a 26.5% stake in Cogentix Medical, Inc. |
| 03/26/2018 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 03/26/2018 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 03/21/2018 |
SC 13D
| Camden Merger Sub, Inc. reports a 59.4% stake in COGENTIX MEDICAL, INC. |
| 03/21/2018 |
SC 13D/A
| PELL LEWIS C reports a 32.9% stake in Cogentix Medical, Inc. |
| 03/21/2018 |
5
| Zauberman Howard I. (Director) has filed a Form 5 on COGENTIX MEDICAL INC /DE/ |
| 03/12/2018 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 03/12/2018 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...|
Docs:
|
"Agreement and Plan of Merger, by and among LM US Parent, Inc., Camden Merger Sub, Inc. and Cogentix Medical, Inc",
"Amendment to Amended and Restated By-laws of Cogentix Medical, Inc",
"Tender and Support Agreement, by and among LM US Parent, Inc., Camden Merger Sub, Inc. and Lewis C. Pell",
"Tender and Support Agreement, by and among LM US Parent, Inc., Camden Merger Sub, Inc. and Accelmed Growth Partners, L.P",
"Cogentix Medical Enters Definitive Merger Agreement to",
"Email communication to employees of Cogentix Medical, Inc." |
|
| 03/12/2018 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2018 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 11/13/2017 |
10-Q
| Quarterly Report for the period ended September 30, 2017 |
| 11/07/2017 |
8-K
| Quarterly results |
| 08/11/2017 |
10-Q
| Quarterly Report for the period ended June 30, 2017 |
| 08/01/2017 |
8-K
| Quarterly results |
| 07/18/2017 |
8-K
| Quarterly results |
| 06/06/2017 |
8-K
| Form 8-K - Current report |
| 05/24/2017 |
8-K
| Form 8-K - Current report |
| 05/23/2017 |
CT ORDER
| Form CT ORDER - Confidential treatment order |
|